Clinical trial
Cardiac Resynchronization Therapy Efficacy Enhancements
NCT02222818 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiac Resynchronization Therapy Efficacy Enhancements
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- January 31, 2016
- Enrollment
- 71 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.